iRhythm Holdings, Inc. (IRTC) Fair Value 2026

IRTC · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.1 /10

32 fundamental signals · 2 models active

Value Trap Risk

SAFE (13/100)

Quick Summary — As of 2026-08-28, iRhythm Holdings, Inc. (IRTC) trades at $120.25, versus a $31.10 median fair value across its 2 active models — 74.1% below the current price. QOC: 7.1/10. Value Trap Risk: 13/100 (SAFE). 2/13 models active.

Key Facts

Ticker
IRTC
Price
$120.25
Quality Score
7.1/10
Value Trap Risk
13/100
Models Active
2/13
Last Updated
Strength: 2 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

Is iRhythm Holdings, Inc. (IRTC) Undervalued or Overvalued in 2026?

According to CirclFi’s 2-model valuation engine, iRhythm Holdings, Inc. (IRTC) appears overvalued as of : the median of 2 independent fair value estimates is $31.10, 74.1% below the current price of $120.25. Estimates range from $25.21 to $36.99. IRTC scores 7.1/10 on fundamental quality and 13/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. IRTC’s -74.1% gap is wider than that market norm, and the Medical Devices sector median is -43.7%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy iRhythm Holdings, Inc. Stock in 2026? →

What Fair Value Does Each Model Give IRTC?

2 Intrinsic Value Models vs. Current Price ($120.25)

Core Models (Unlocked)
Model Fair Value Upside
Relative · Medium Conviction
 $36.99 -69.2%
Relative · Low Conviction
 $25.21 -79.0%

All Models Active

All 2 models are displayed above.

What Is iRhythm Holdings, Inc. (IRTC) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, iRhythm Holdings, Inc.'s intrinsic value is estimated at $31.10. Trading at its current price of $120.25, the valuation engine raises significant caution: 2 of 2 models flag downside risk, projecting a median implied return of -74.1%.

What Do the Models Say About IRTC?

2 of 13 models are currently active for IRTC. All 2 active models suggest the stock trades above fair value. Taken together, their median fair value for IRTC is $31.10 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does IRTC Rank in Medical Devices?

Among 159 Medical Devices stocks, IRTC ranks #48 by Quality of Company score. CirclFi's QOC score of 7.1/10 evaluates 32 fundamental signals. A score of 7.1 indicates above-average quality.

See all Most Undervalued Medical Devices Stocks →

iRhythm Holdings, Inc.'s positioning within the Medical Devices segment means that patent cliff exposure plays an outsized role in fundamental analysis. The sector's unique characteristics — including therapeutic area leadership — shape both the opportunity set and risk profile.

Is IRTC a Value Trap?

CirclFi's Value Trap algorithm assigns IRTC a score of 13/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

2 of 13 models are active for iRhythm Holdings, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, iRhythm Holdings, Inc. earns a quality score of 7.1/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

Models cluster within a tight range (+9.8% spread), increasing conviction. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every IRTC valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across IRTC's 2 active models, average confidence is 30%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy iRhythm Holdings, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

LNSRLENSAR, Inc.QOC 7.1MASS908 Devices Inc.QOC 7.1NVCRNovoCure LimitedQOC 7.1ESTAEstablishment Labs Holdings Inc.QOC 7.0KIDSOrthoPediatrics Corp.QOC 7.1MXCTMaxCyte, Inc.QOC 7.0BBNXBeta Bionics, Inc.QOC 6.1HSCSHeartSciences Inc.QOC 4.9SYKStryker CorporationQOC 9.0IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: LNSR · MASS · NVCR · ESTA · KIDS · MXCT · BBNX · HSCS · SYK · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to IRTC?

7 companies across all industries closest to IRTC’s Quality of Company score of 7.1/10.

PTLOPortillo's Inc.QOC 7.1TWITitan International, Inc.QOC 7.1SSentinelOne, Inc.QOC 7.1CISSC3is Inc.QOC 7.1CIBGrupo Cibest S.A.QOC 7.1BEKEKE Holdings Inc.QOC 7.1NVDANVIDIA CorporationQOC 10.0

Read investment analysis: PTLO · TWI · S · CISS · CIB · BEKE · NVDA

Where Does IRTC Sit in CirclFi's Medical Devices Rankings?

IRTC is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About iRhythm Holdings, Inc.’s Valuation?

What is iRhythm Holdings, Inc.'s intrinsic value in 2026?

CirclFi puts iRhythm Holdings, Inc. (IRTC)'s intrinsic value at $31.10 — the median of 2 independent model estimates as of 2026-08-28, ranging from $25.21 to $36.99. The Quality of Company score is 7.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is IRTC overvalued or undervalued right now?

At $120.25, 0 of 2 active models suggest IRTC may be undervalued, while 2 indicate potential overvaluation. The median of all 2 fair value estimates is $31.10, 74.1% below the current price of $120.25 — a consensus view that IRTC is overvalued. The assessment depends on which methodology best fits iRhythm Holdings, Inc.'s business model in Medical Devices.

What does a Quality of Company score of 7.1 mean for IRTC?

iRhythm Holdings, Inc.'s QOC of 7.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on IRTC?

CirclFi analyzes IRTC with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 2 of 13 are active for this stock. Read the full methodology →

Is IRTC a value trap in 2026?

iRhythm Holdings, Inc.'s Value Trap score is 13/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 2-model valuation engine, iRhythm Holdings, Inc. (IRTC) has a median fair value of $31.10 — 74.1% below the current price of $120.25 — as of 2026-08-28.” Source: circlfi.com/stock/IRTC/ · Methodology
Primary sources for this IRTC valuation
  • Financial statements: iRhythm Holdings, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001388658) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for IRTC as of ; valuations recomputed .